NEW YORK - Pfizer Inc. said on Wednesday clinical studies of its insulin
drug Exubera found increased cases of lung cancer, leading developer Nektar to
abandon the troubled product.
April 9, 2008
From the News Wire: Pfizer Warns of Lung Cancer Risk on Inhaled Insulin
Hmmm isn't this what everyone was asking about all along?